A célzott terápia - Paradigmaváltás az onkológiában

Translated title of the contribution: The targeted therapy - Changing of the paradigm in oncology

Research output: Contribution to journalArticle

Abstract

Traditional anticancer therapy reached its limits to increase progression free or overail survival in almost all malignancies. A substantial change (can be called as changes in the: paradigm) is advocated by the high-speed activity to understand the key molecular basis of i the development, growth and progression of neoplasia in order to use these informations for i therapeutic targeting. There are several hot areas in this respect, especially the signal j transducing pathways and antiangiogenesis to decrease survival, and to inhibit vascular; supply. The most effective approaches use combination therapy and/or multitargeting I agents. To achieve further improvements it is essential to maintain very close partnership I between the diagnostic and therapeutic teams.

Original languageHungarian
Pages (from-to)157-161
Number of pages5
JournalOrvoskepzes
Volume84
Issue number3
Publication statusPublished - 2009

Fingerprint

Therapeutics
Growth and Development
Blood Vessels
Neoplasms
3-chloro-4,4-dimethyl-2-oxazolidinone

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A célzott terápia - Paradigmaváltás az onkológiában. / Kópper, L.

In: Orvoskepzes, Vol. 84, No. 3, 2009, p. 157-161.

Research output: Contribution to journalArticle

@article{6f371226f90649fd88b0943b06442a03,
title = "A c{\'e}lzott ter{\'a}pia - Paradigmav{\'a}lt{\'a}s az onkol{\'o}gi{\'a}ban",
abstract = "Traditional anticancer therapy reached its limits to increase progression free or overail survival in almost all malignancies. A substantial change (can be called as changes in the: paradigm) is advocated by the high-speed activity to understand the key molecular basis of i the development, growth and progression of neoplasia in order to use these informations for i therapeutic targeting. There are several hot areas in this respect, especially the signal j transducing pathways and antiangiogenesis to decrease survival, and to inhibit vascular; supply. The most effective approaches use combination therapy and/or multitargeting I agents. To achieve further improvements it is essential to maintain very close partnership I between the diagnostic and therapeutic teams.",
keywords = "Signal transduction, Target therapy, Targeted therapy",
author = "L. K{\'o}pper",
year = "2009",
language = "Hungarian",
volume = "84",
pages = "157--161",
journal = "Orvoskepzes",
issn = "0030-6037",
publisher = "Semmelweis Kiado",
number = "3",

}

TY - JOUR

T1 - A célzott terápia - Paradigmaváltás az onkológiában

AU - Kópper, L.

PY - 2009

Y1 - 2009

N2 - Traditional anticancer therapy reached its limits to increase progression free or overail survival in almost all malignancies. A substantial change (can be called as changes in the: paradigm) is advocated by the high-speed activity to understand the key molecular basis of i the development, growth and progression of neoplasia in order to use these informations for i therapeutic targeting. There are several hot areas in this respect, especially the signal j transducing pathways and antiangiogenesis to decrease survival, and to inhibit vascular; supply. The most effective approaches use combination therapy and/or multitargeting I agents. To achieve further improvements it is essential to maintain very close partnership I between the diagnostic and therapeutic teams.

AB - Traditional anticancer therapy reached its limits to increase progression free or overail survival in almost all malignancies. A substantial change (can be called as changes in the: paradigm) is advocated by the high-speed activity to understand the key molecular basis of i the development, growth and progression of neoplasia in order to use these informations for i therapeutic targeting. There are several hot areas in this respect, especially the signal j transducing pathways and antiangiogenesis to decrease survival, and to inhibit vascular; supply. The most effective approaches use combination therapy and/or multitargeting I agents. To achieve further improvements it is essential to maintain very close partnership I between the diagnostic and therapeutic teams.

KW - Signal transduction

KW - Target therapy

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=82455216870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455216870&partnerID=8YFLogxK

M3 - Article

VL - 84

SP - 157

EP - 161

JO - Orvoskepzes

JF - Orvoskepzes

SN - 0030-6037

IS - 3

ER -